According to our (Global Info Research) latest study, the global Medical Radioactive Microspheres market size was valued at US$ 219 million in 2025 and is forecast to a readjusted size of US$ 450 million by 2032 with a CAGR of 10.9% during review period.
Medical radioactive microspheres are a type of radioactive embolic agent that uses interventional means to inject micron-sized particles (usually 20-45 microns in diameter) containing radionuclides (such as yttrium [90Y]) into the tumor's blood supply artery. The carrier material is mostly ceramic, resin or glass. It releases beta rays through targeted tumors (to kill tumor cells at close range, and at the same time has the function of embolizing blood vessels, which can significantly improve the local control rate of tumors and reduce normal tissue damage. It is mainly used clinically for the treatment of solid tumors such as primary liver cancer and colorectal cancer liver metastasis that cannot be surgically removed. It has the advantages of high targeting, few side effects, and reliable efficacy, and can meet individualized treatment needs through customized personalized activity.
Future development trends, driving factors and obstacles of medical radioactive microspheres
Application field expansion
At present, medical radioactive microspheres are mainly used for liver cancer treatment, but in the future they are expected to be expanded to the treatment of other malignant tumors such as pancreatic cancer, bladder cancer, head and neck cancer, etc. In addition, with the advancement of technology, radioactive microspheres may play a greater role in the treatment of benign diseases.
Technological innovation and product upgrade
The preparation technology of radioactive microspheres will continue to be optimized, such as developing microspheres with smaller particle size and more uniform distribution to improve the treatment effect and reduce side effects. At the same time, the research on visual microspheres will promote the development of real-time monitoring technology, enabling doctors to control the distribution and dosage of microspheres more accurately.
Intensified market competition
As market demand grows, more and more companies will enter the field of medical radioactive microspheres, and market competition will become more intense. At present, major global manufacturers include Sirtex Medical and Boston Scientific Corporation, and more new players may emerge in the future.
Development drivers
Increasing cancer incidenc
The global cancer incidence rate is increasing year by year, especially malignant tumors such as liver cancer. According to the World Health Organization, liver cancer is the sixth most common cancer in the world and the third leading cause of cancer death. As an effective local treatment method, the market demand for radioactive microspheres will continue to grow.
Technological progress
The preparation technology and application technology of radioactive microspheres are constantly improving. For example, the research and application of yttrium [90Y] microspheres make treatment more accurate and safe. In addition, the research on visualized microspheres will further improve the controllability and effect of treatment.
Policy support
Governments of various countries have continuously increased their support for medical technology, especially in the field of cancer treatment. For example, China has introduced a series of policies to support the development of biopharmaceuticals and traditional Chinese medicine industries, and promote the industrialization of technologies such as sustained-release preparations and targeted preparations.
Development obstacles
Technical barriers
The preparation technology of medical radioactive microspheres is complex and requires high-precision equipment and processes. At present, domestic companies still have a certain gap in microsphere preparation technology, relying on imported materials and equipment, which increases production costs and supply chain uncertainty.
Market competition and price pressure
With the intensification of market competition, price pressure will increase. How to reduce production costs and improve market competitiveness while ensuring product quality and efficacy is a challenge faced by companies.
Regulation and approval
As medical devices, medical radioactive microspheres need to undergo strict supervision and approval. Different regulatory requirements in different countries and regions increase the difficulty and time cost of bringing products to market.
This report is a detailed and comprehensive analysis for global Medical Radioactive Microspheres market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Radioactive Microspheres market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Medical Radioactive Microspheres market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Medical Radioactive Microspheres market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Medical Radioactive Microspheres market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Radioactive Microspheres
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Radioactive Microspheres market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include New Radiomedicine Technology, Grand Pharmaceutical Group Limited, YH Nu-Med, Boston Scientific, Sirtex Medical Limited, Terumo, ABK Biomedical, AtomVie, BWXT Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Radioactive Microspheres market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Holmium-166 Microspheres
Yttrium-90 Microspheres
Market segment by Application
Cancer Treatment
Diagnosis
Others
Major players covered
New Radiomedicine Technology
Grand Pharmaceutical Group Limited
YH Nu-Med
Boston Scientific
Sirtex Medical Limited
Terumo
ABK Biomedical
AtomVie
BWXT Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Radioactive Microspheres product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Radioactive Microspheres, with price, sales quantity, revenue, and global market share of Medical Radioactive Microspheres from 2021 to 2026.
Chapter 3, the Medical Radioactive Microspheres competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Radioactive Microspheres breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Radioactive Microspheres market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Radioactive Microspheres.
Chapter 14 and 15, to describe Medical Radioactive Microspheres sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Medical Radioactive Microspheres. Industry analysis & Market Report on Medical Radioactive Microspheres is a syndicated market report, published as Global Medical Radioactive Microspheres Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medical Radioactive Microspheres market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.